Nikhil Dattatray Avalaskar

Title: Nikhil Dattatray Avalaskar: Innovator in Vaccine Stabilization

Introduction

Nikhil Dattatray Avalaskar is a prominent inventor based in Pune, India. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His innovative work focuses on the stabilization of biological molecules, which is crucial for the efficacy of vaccines.

Latest Patents

Nikhil holds a patent for a method that enhances the stabilization of biological molecules. The patent, titled "Method for stabilization of biological molecules," specifically addresses thermostable polysaccharide-based lyophilized vaccines. This invention includes polysaccharide-protein conjugate vaccines and outlines methods for their preparation. In an exemplary embodiment, the stabilized vaccine composition consists of at least one polysaccharide-protein conjugate, at least one amorphous excipient, and a buffer component. He has 1 patent to his name.

Career Highlights

Nikhil is currently employed at the Serum Institute of India Private Limited, a leading organization in vaccine production. His role involves research and development, where he applies his expertise to create innovative solutions in vaccine technology.

Collaborations

Nikhil has collaborated with notable colleagues, including Subhash Vinayak Kapre and Sambhaji Shankar Pisal. These collaborations have furthered his research and contributed to advancements in the field.

Conclusion

Nikhil Dattatray Avalaskar is a key figure in the biotechnology sector, with a focus on vaccine stabilization. His innovative patent and work at the Serum Institute of India Private Limited highlight his commitment to improving public health through advanced vaccine technologies.